Oral p38 mitogen-activated protein kinase inhibition with BIRB 796 for active Crohn's disease: a randomized, double-blind, placebo-controlled trial

Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
S SchreiberBIRB 796 Study Group

Abstract

The p38 mitogen-activated protein kinase (MAPK) regulates the expression of proinflammatory cytokines, which play a critical role in the pathophysiology of Crohn's disease (CD). This study investigated the efficacy and safety of BIRB 796, a highly potent inhibitor of p38 MAPK, in chronic active CD. In a multicenter, multinational trial, 284 patients with moderate to severe CD were randomized to receive placebo, or 10, 20, 30, or 60 mg of BIRB 796 twice daily for 8 weeks. Clinical endpoints were based on standard safety assessments, CD Activity Index, C-reactive protein levels, and quality of life (Inflammatory Bowel Disease Questionnaire). In a substudy, the Crohn's Disease Endoscopic Index of Severity and histologic results of biopsy specimens were assessed. No clinical efficacy (primary end point, clinical remission; secondary end point, clinical response; Inflammatory Bowel Disease Questionnaire; Crohn's Disease Endoscopic Index of Severity) was seen for BIRB 796 in comparison with placebo. A significant, dose-dependent decrease of C-reactive protein level was observed transiently after BIRB 796 after 1 week with a return to baseline level over time. The incidence of adverse events was comparable between all treatment groups...Continue Reading

References

Nov 18, 2000·Lancet·S NikolausS Schreiber
Mar 16, 2002·Nature Structural Biology·Christopher PargellisJohn Regan
Jun 6, 2002·Lancet·Stephen B HanauerUNKNOWN ACCENT I Study Group
Jun 14, 2003·Gastroenterology·Jan M H Van den BrandeSander J H van Deventer

❮ Previous
Next ❯

Citations

Feb 20, 2007·Inflammatory Bowel Diseases·Giovanni LatellaRenzo Caprilli
Feb 2, 2013·Drugs·Verica Paunovic, Margaret M Harnett
Feb 19, 2010·Current Opinion in Rheumatology·Stanley Cohen, Roy Fleischmann
Jan 24, 2008·Transplantation·Robert OllingerRaimund Margreiter
Apr 21, 2012·Journal of Gastroenterology and Hepatology·Trevor A Winter, Susan Y Quan
Oct 14, 2006·Annals of the Rheumatic Diseases·S E Sweeney, G S Firestein
Jan 9, 2010·Annals of the Rheumatic Diseases·D Hammaker, G S Firestein
Dec 4, 2012·The Journal of Clinical Investigation·Bárbara González-TeránGuadalupe Sabio
Oct 13, 2012·Proceedings of the Japan Academy. Series B, Physical and Biological Sciences·Ryoichi HayakawaHidenori Ichijo
Sep 30, 2010·Immunotherapy·Aiping Bai, Zhikang Peng
Feb 8, 2014·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Marie FiskJoseph Cheriyan
Apr 20, 2013·Annals of the Rheumatic Diseases·Eva SalgadoJuan J Gomez-Reino
Oct 13, 2011·Expert Opinion on Pharmacotherapy·Mario CottoneFilippo Mocciaro
Jan 1, 2008·Expert Review of Clinical Immunology·Bozena Kaminska, Karolina Swiatek-Machado
Feb 12, 2011·Expert Review of Gastroenterology & Hepatology·Anja Schirbel, Claudio Fiocchi
Jul 30, 2010·Expert Opinion on Pharmacotherapy·Sheila A Doggrell, Anne-Marie Christensen
Oct 13, 2007·Expert Opinion on Pharmacotherapy·A R Bremner, R M Beattie
Aug 21, 2007·Expert Opinion on Biological Therapy·C Janneke van der Woude, Daniel W Hommes
Sep 1, 2010·Expert Opinion on Drug Discovery·Susanne Müller, Stefan Knapp
Oct 27, 2009·Expert Opinion on Investigational Drugs·Hae-Young YongAree Moon
Sep 15, 2010·Expert Opinion on Investigational Drugs·Mario CottoneSara Renna
Jul 7, 2007·Immunology·David A Medina-TatoMalcolm L Watson
May 1, 2010·Autoimmunity·Soo-In Choi, Ernest Brahn
May 15, 2007·Lancet·Daniel C Baumgart, William J Sandborn
May 8, 2007·Biochimica Et Biophysica Acta·Ana Cuenda, Simon Rousseau
Oct 27, 2016·Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals·Irene D RománLuis G Guijarro
Nov 5, 2008·Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas·F Y MaD J Nikolic-Paterson
Aug 28, 2007·Journal of Dental Research·J F SchindlerW G Smith

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2021 Meta ULC. All rights reserved